Vanguard Group Inc Meridian Bioscience Inc Transaction History

Vanguard Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$31.15 - $33.39 $1.3 Million - $1.4 Million	41,857 Added 0.85%	4,970,105 $165 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $747,718 - $811,842	24,198 Added 0.49%	4,928,248 $155 Million
Q2 2022 Aug 12, 2022	BUY	$23.75 - $31.69 $2.67 Million - $3.57 Million	112,548 Added 2.35%	4,904,050 $149 Million
Q1 2022 May 13, 2022	SELL	$19.97 - $26.94 $1.71 Million - $2.3 Million	-85,440 Reduced 1.75%	4,791,502 $124 Million
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $2.21 Million - $2.74 Million	-126,680 Reduced 2.53%	4,876,942 $99.5 Million
Q3 2021 Nov 12, 2021	SELL	$17.35 - $22.5 $1.23 Million - $1.6 Million	-71,162 Reduced 1.4%	5,003,622 $96.3 Million
Q2 2021 Aug 13, 2021	BUY	$18.01 - $28.32 $91.4 Million - $144 Million	5,074,784 New	5,074,784 $113 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.